Fri, 25th Oct 2013 15:28
LONDON (Alliance News) - Hikma Pharmaceuticals PLC Friday said Non-Executive Chairman Samih Darwazah sold 100,000 shares at a price of GBP11.48.
Following this transaction, Darwazah now holds 13 million shares, which represents a 6% stake in the firm.
The stock was trading at 1,149.00 pence Friday afternoon, up 1.00 pence or 0.1%.
By Anthony Tshibangu; anthonytshibangu@alliancenews.com; @AnthonyAllNews
Copyright 2013 Alliance News Limited. All Rights Reserved.
(Alliance News) - Hikma Pharmaceuticals PLC on Monday bolstered its US and injectables business with the purchase of assets from Denmark's Xellia Phar...
(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Ba...
(Sharecast News) - Hikma Pharmaceuticals said on Monday that it has agreed to buy parts of Xellia Pharmaceuticals, a Copenhagen-based specialty compan...
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:
(Sharecast News) - Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "hea...
Hikma Pharmaceuticals (HIK)